Risk of mortality among individual antipsychotics in patients with dementia

American Journal of Psychiatry

Volumn 169, Issue 1, 2012, Pages 71-79

  Kales, Helen C ^a,b,c,d   Kim, Hyungjin Myra ^a,b,c,d   Zivin, Kara ^a,b,c,d   Valenstein, Marcia ^a,b,c,d   Seyfried, Lisa S ^a,b,c,d   Chiang, Claire ^a,b,c,d   Cunningham, Francesca ^a,b,c,d   Schneider, Lon S ^a,b,c,d   Blow, Frederic C ^a,b,c,d  

^a Ann Arbor VA Center for Clinical Management Research Serious Mental Illness Treatment Resource and Evaluation Center ^*  (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Pharmacoepidemiologic/Outcomes Research   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; VALPROATE SEMISODIUM; VALPROIC ACID; BENZODIAZEPINE DERIVATIVE; DIBENZOTHIAZEPINE DERIVATIVE;

AGED; ARTICLE; BEHAVIOR DISORDER; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTPATIENT; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; PROPENSITY SCORE; RETROSPECTIVE STUDY; UNITED STATES; RISK; TIME;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DEMENTIA; DIBENZOTHIAZEPINES; FEMALE; HALOPERIDOL; HUMANS; MALE; PROPENSITY SCORE; RETROSPECTIVE STUDIES; RISK; RISPERIDONE; TIME FACTORS; VALPROIC ACID;

EID: 84863115465     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2011.11030347     Document Type: Article

References (29)

1. Saha S, Robinson S, Bainco T, Schechtel M, Hickam D: Off-Label Use of Atypical Antipsychotic Drugs: A Summary for Clinicians and Policy Makers. Rockville, Md, Agency for Healthcare Research and Quality, 2007. www.effectivehealthcare.ahrq.gov/repFiles/Atypical-Antipsychotics-Off-Label-Use. pdf
2. Schneider LS, Dagerman KS, Insel P: Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005; 294:1934-1943 (Pubitemid 41464695)
3. Kales HC, Valenstein M, Kim HM, McCarthy JF, Ganoczy D, Cunningham F, Blow FC: Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. Am J Psychiatry 2007; 164:1568-1576 (Pubitemid 350069737)
4. Gill SS, Bronskill SE, Normand SL, Anderson GM, Sykora K, Lam K, Bell CM, Lee PE, Fischer HD, Herrmann N, Gurwitz JH, Rochon PA: Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 2007; 146:775-786 (Pubitemid 351650498)
5. Ballard C, Hanney M, Theodoulou M, Douglas S, McShane R, Kossakowski K, Gill R, Juszczak E, Yu L-M, Jacoby R: The Dementia Antipsychotic Withdrawal Trial (DART-AD): long-term follow-up of a randomized placebo-controlled trial. Lancet Neurol 2009; 8:151-157
6. FDA: Safety Labeling Changes for Antipsychotic Drugs. 2008. http://www.fda.gov/downloads/NewsEvents/Newsroom/MediaTranscripts/UCM169331.pdf
7. Kryzhanovskaya L, Jeste D, Young C, Polzer J, Roddy T, Jansen J, Carlson J, Cavazzoni P: A review of treatment-emergent adverse events during olanzapine clinical trials in elderly patients with dementia. J Clin Psychiatry 2006; 67:933-945 (Pubitemid 44049092)
8. Schneeweiss S, Setoguchi S, Brookhart A, Dormuth C, Wang PS: Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. CMAJ 2007; 176:627-632 (Pubitemid 46426056)
9. Rossom RC, Rector TS, Lederle FA, Dysken MW: Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia? J Am Geriatr Soc 2010; 58:1027-1034
10. Kales HC, Zivin K, Kim HM, Valenstein M, Chiang C, Ignacio RV, Ganoczy D, Cunningham F, Schneider LS, Blow FC: Trends in antipsychotic use in dementia, 1999-2007. Arch Gen Psychiatry 2011; 68:190-197
11. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-383 (Pubitemid 17055592)
12. Adamis D, Treloar A, Martin FC, Macdonald AJ: Recovery and outcome of delirium in elderly medical inpatients. Arch Gerontol Geriatr 2006; 43:289-298 (Pubitemid 44251228)
13. Kales HC, Kamholz BA, Visnic SG, Blow FC: Recorded delirium in a national sample of elderly inpatients: potential implications for recognition. J Geriatr Psychiatry Neurol 2003; 16:32-38 (Pubitemid 37408288)
14. Wang PS, Schneeweiss S, Avorn J, Fischer MA, Mogun H, Solomon DH, Brookhart MA: Risk of death in elderly users of conventional vs atypical antipsychotic medications. N Engl J Med 2005; 353:2335-2341 (Pubitemid 41713745)
15. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Statistical Assoc 1958; 53:457-481
16. Rosenbaum PR, Rubin DB: The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70:41-55
17. Andreasen N, Pressler M, Nopoulos P, Miller D, Ho B-C: Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry 2010; 67:255-262
18. Lopez O, Becker J, Sweet R, Klunk W, Kaufer D, Saxton J, DeKosky S: Patterns of change in the treatment of psychiatric symptoms in patients with probable Alzheimer's disease from 1983 to 2000. J Neuropsychiatry Clin Neurosci 2003; 15:67-67
19. Rapoport M, Mamdani M, Shulman KI, Herrmann N, Rochon PA: Antipsychotic use in the elderly: shifting trends and increasing costs. Int J Geriatr Psychiatry 2005; 20:749-753 (Pubitemid 41158720)
20. Schneider LS, Dagerman K, Insel PS: Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 2006; 14:191-210
21. Schneeweiss S, Setoguchi S, Brookhart MA, Kaci L, Wang P: Assessing residual confounding of the association between antipsychotic medications and risk of death using survey data. CNS Drugs 2009; 23:171-180
22. Mezuk B, Morden N, Ganoczy D, Post E, Kilbourne A: Anticonvulsant use, bipolar disorder, and risk of fracture among older adults in the Veterans Health Administration. Am J Geriatr Psychiatry 2010; 18:245-255
23. Porsteinsson AP, Tariot PN, Erb R, Cox C, Smith E, Jakimovich L, Noviasky J, Kowalski N, Holt CJ, Irvine C: Placebo-controlled study of divalproex sodium for agitation in dementia. Am J Geriatric Psychiatry 2001; 9:58-66 (Pubitemid 32062073)
24. Tariot P, Loy R, Ryan JM, Porsteinsson A, Ismail S: Mood stabilizers in Alzheimer's disease: symptomatic and neuroprotective rationales. Adv Drug Deliv Rev 2002; 54:1567-1577 (Pubitemid 35346831)
25. Tariot P, Raman R, Jakimovich L, Schneider L, Porsteinsson A, Thomas R, Mintzer J, Brenner R, Schafer K, Thal L: Divalproex sodium in nursing home residents with possible or probable Alzheimer disease complicated by agitation: a randomized, controlled trial. Am J Geriatric Psychiatry 2005; 13:942-949 (Pubitemid 46638660)
26. US Food and Drug Administration: Deaths With Antipsychotics in Elderly Patients With Behavioral Disturbances. Washington, DC, US Department of Health and Human Services, 2005. http://psychrights.org/Drugs/ FDAatypicalswarning4elderly.pdf
27. Lyketsos C, Colenda C, Beck C, Blank K, Doriaswamy M, Kalunian D, Yaffe K, Task Force of American Association for Geriatric Psychiatry: Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. Am J Geriatr Psychiatry 2006; 14:561-572 (Pubitemid 44036480)
28. Langa K, Plassman B, Wallace R, Herzog AR, Heeringa S, Ofstedal M, Burke J, Fisher G, Fultz N, Hurd M, Potter GG, Rodgers WL, Steffens DC, Weir DR, Willis RJ: The Aging, Demographics, and Memory Study: study design and methods. Neuroepidemiology 2005; 25:181-191 (Pubitemid 41540659)
29. Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, Steffens DC, Willis RJ, Wallace RB: Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology 2007; 29:125-132 (Pubitemid 350191430)